Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #33,501 to #33,550.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Moyamoya disease screening (2 revisions)
  2. Moyamoya disease secondary prevention (2 revisions)
  3. Mpemba effect (2 revisions)
  4. Msh homeobox 2 (2 revisions)
  5. Mt-rnr2-like 4 (2 revisions)
  6. Mu phage (2 revisions)
  7. Mucin 4 (2 revisions)
  8. Mucin 5AC (2 revisions)
  9. Mucinous cystadenocarcinoma chest x ray (2 revisions)
  10. Mucinous cystadenocarcinoma diagnostic study of choice (2 revisions)
  11. Mucinous cystadenocarcinoma screening (2 revisions)
  12. Mucocutaneous myxoma (2 revisions)
  13. Mucoepidermoid carcinoma chest x ray (2 revisions)
  14. Mucoepidermoid carcinoma electrocardiogram (2 revisions)
  15. Right border of heart (2 revisions)
  16. Right bundle branch block (patient information) (2 revisions)
  17. Right bundle branch block classification (2 revisions)
  18. Right colic artery (2 revisions)
  19. Right colic vein (2 revisions)
  20. Right gastric artery (2 revisions)
  21. Right gastric vein (2 revisions)
  22. Right marginal vein (2 revisions)
  23. Right ventricular outflow tract obstruction demographics and epidemiology (2 revisions)
  24. Right ventricular outflow tract obstruction etiology (2 revisions)
  25. Right ventricular outflow tract obstruction indications for invasive studies (2 revisions)
  26. Right ventricular outflow tract obstruction normal pulmonary valve anatomy (2 revisions)
  27. Rilmazafone (2 revisions)
  28. Rilotumumab (2 revisions)
  29. Rilpivirine contraindications (2 revisions)
  30. Rilpivirine description (2 revisions)
  31. Rilpivirine dosage and administration (2 revisions)
  32. Rilpivirine drug interactions (2 revisions)
  33. Rilpivirine how supplied (2 revisions)
  34. Rilpivirine indications and usage (2 revisions)
  35. Rilpivirine labels and packages (2 revisions)
  36. Rilpivirine overdosage (2 revisions)
  37. Rilpivirine warnings and precautions (2 revisions)
  38. Rimantadine adverse reactions (2 revisions)
  39. Rimantadine clinical pharmacology (2 revisions)
  40. Rimantadine dosage and administration (2 revisions)
  41. Risankizumab (2 revisions)
  42. Risedronate sodium (patient information) (2 revisions)
  43. Risk factor (2 revisions)
  44. Risk stratification tools (2 revisions)
  45. Risperidone (patient information) (2 revisions)
  46. Risperidone detailed information (2 revisions)
  47. Ristocetin (2 revisions)
  48. Ritlecitinib (2 revisions)
  49. Ritonavir clinical pharmacology (2 revisions)
  50. Ritonavir description (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"